TP53 and cancer: In response to the injection of CCl4 in mice followed by treating these mice with compound 4d, the p53, caspase 3, and Ki-67 were activated and increased in order to stop the proliferation of premalignant cancer cells and, at the same time, to regenerate the damaged hepatocytes.